ArticleThe Journal of clinical and aesthetic dermatology2012
An Update on the Treatment of the Cutaneous Manifestations of Systemic Sclerosis: The Dermatologist's Point of View.
Article in The Journal of clinical and aesthetic dermatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 32 citations in OpenAlex.
- The effects of upper and lower limb exercise on the microvascular reactivity in limited cutaneous systemic sclerosis patients.Arthritis research & therapy · 2018Trial
- Calcinosis Prevalence in Autoimmune Connective Tissue Diseases-A Retrospective Study.Journal of clinical medicine · 2024Article
- [Systemic sclerosis].Dermatologie (Heidelberg, Germany) · 2024Review
- The Role of Autophagy and Apoptosis in Affected Skin and Lungs in Patients with Systemic Sclerosis.International journal of molecular sciences · 2023Review
- Regression of calcinosis cutis after inkless tattoo in a patient with dermatomyositis: therapeutic potential of microneedling.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022Article
- Clinical and ultrasound response to intralesional sodium thiosulfate for the treatment of calcinosis cutis in the setting of systemic sclerosis. A case-based review.Clinical rheumatology · 2021Review
- Fat Grafting Subjectively Improves Facial Skin Elasticity and Hand Function of Scleroderma Patients.Plastic and reconstructive surgery. Global open · 2021Article
- MicroRNA expression analysis of human skin fibroblasts treated with high-fluence light-emitting diode-red light.Journal of biophotonics · 2019Article
- Review
- Clinical, biochemical, and radiological characterization of the calcinosis in a cohort of Mexican patients with systemic sclerosis.Clinical rheumatology · 2017Article
- High fluence light emitting diode-generated red light modulates characteristics associated with skin fibrosis.Journal of biophotonics · 2016Article
- Digital ulcers in scleroderma patients: A retrospective observational study.International journal of immunopathology and pharmacology · 2016Observational
- Identification of clinical features and autoantibodies associated with calcinosis in dermatomyositis.JAMA dermatology · 2014Article
- Visible Red Light Emitting Diode Photobiomodulation for Skin Fibrosis: Key Molecular Pathways.Current dermatology reportsReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Systemic sclerosis is a connective tissue disorder that affects multiple organs. Although the initial symptoms of the disease are vascular, skin involvement is almost universally present in patients with systemic sclerosis. The presence of Raynaud's phenomenon, progressive thickening of the skin, digital ulcers, and calcinosis all correlate proportionally with disease severity. Since no treatment is available to completely prevent the natural course of the disease, emphasis is often placed on managing symptoms and complications. In this review, the authors focus on the management of each one of the skin manifestations seen in systemic sclerosis, as the dermatologist may facilitate the early recognition and treatment of these complications.
Identifiers
22798974PMC3396456W1559096478What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.